Karl Bartmann
Impact in
-
- Antibiotic Resistance in Bacteria
-
- Tuberculosis Research and Epidemiology
Papers in
-
- Tuberculosis Research and Epidemiology 27
- Epidemiology 24
- Mycobacterium research and diagnosis 14
- Pneumonia and Respiratory Infections 6
- Co-authors
- Imre Zs.-Nagy (1 shared paper)Manfred Plempel (1 shared paper)L Trnka (1 shared paper)Harald Reinert (1 shared paper)Tilman E. Kuhn (1 shared paper)Lars Bergmann (1 shared paper)S Tuengerthal (1 shared paper)P.S. Mitrou (1 shared paper)
- Journals
- Lung (23 papers)Infection (5 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (4 papers)Handbook of experimental pharmacology (2 papers)Medical Microbiology and Immunology (1 paper)
- Partner nations
- GermanyUnited KingdomRomania
In The Last Decade
Karl Bartmann
54 papers receiving 179 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 29
- Infectious Diseases 97
- Epidemiology 85
- Pharmacology 37
- Pharmacology 19
Countries citing papers authored by Karl Bartmann
This map shows the geographic impact of Karl Bartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Bartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Bartmann more than expected).
Fields of papers citing papers by Karl Bartmann
This network shows the impact of papers produced by Karl Bartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Bartmann. The network helps show where Karl Bartmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Karl Bartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD). | 1985 | 35 |
| 2 | 1974 | 20 | |
| 3 | 1960 | 12 | |
| 4 | 1961 | 12 | |
| 5 | 1958 | 11 | |
| 6 | Experimental study of a new orally effective broad-spectrum antimyocotic agent. | 1969 | 11 |
| 7 | 2009 | 10 | |
| 8 | 1963 | 9 | |
| 9 | 1982 | 8 | |
| 10 | 1988 | 8 | |
| 11 | 1955 | 8 | |
| 12 | 1960 | 8 | |
| 13 | 1957 | 7 | |
| 14 | 1981 | 6 | |
| 15 | [STUDY ON NEISSERIA IN BRONCHO-PULMONARY INFECTIONS]. | 1963 | 6 |
| 16 | Towards an international standardization of resistance tests on mycobacteria. | 1968 | 6 |
| 17 | 1960 | 6 | |
| 18 | 1956 | 5 | |
| 19 | 1955 | 5 | |
| 20 | [Phase contrast microscopical study of the morphology of peripneumonia-like organisms (PPLO)]. | 1955 | 5 |
About Karl Bartmann
Karl Bartmann is a scholar working on Infectious Diseases, Epidemiology, Immunology, Molecular Medicine and Pharmacology, having authored 77 papers that have together received 290 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (27 papers), Mycobacterium research and diagnosis (14 papers), Immune Response and Inflammation (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Pneumonia and Respiratory Infections (6 papers), Antibiotic Resistance in Bacteria (6 papers), Cytokine Signaling Pathways and Interactions (5 papers) and Pediatric health and respiratory diseases (5 papers). The work is most often cited by research in Molecular Medicine (29 citations), Infectious Diseases (97 citations), Epidemiology (85 citations), Pharmacology (37 citations) and Pharmacology (19 citations). Karl Bartmann has collaborated with scholars based in Germany, United Kingdom and Romania. Frequent co-authors include Imre Zs.-Nagy, Manfred Plempel, L Trnka, Harald Reinert, Tilman E. Kuhn, Lars Bergmann, S Tuengerthal, P.S. Mitrou, Meinhart Rust and J Meier-Sydow. Their work appears in journals such as Lung, Infection, Naunyn-Schmiedeberg s Archives of Pharmacology, Handbook of experimental pharmacology and Medical Microbiology and Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.